These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8875558

  • 21. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
    Saito T, Sato H, Virgona N, Hagiwara H, Kashiwagi K, Suzuki K, Asano R, Yano T.
    Cancer Lett; 2007 Aug 18; 253(2):249-57. PubMed ID: 17343982
    [Abstract] [Full Text] [Related]

  • 22. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor.
    Wan XS, Meyskens FL, Armstrong WB, Taylor TH, Kennedy AR.
    Cancer Epidemiol Biomarkers Prev; 1999 Jul 18; 8(7):601-8. PubMed ID: 10428197
    [Abstract] [Full Text] [Related]

  • 23. The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts.
    Dittmann KH, Gueven N, Mayer C, Ohneseit P, Zell R, Begg AC, Rodemann HP.
    Radiat Res; 1998 Dec 18; 150(6):648-55. PubMed ID: 9840184
    [Abstract] [Full Text] [Related]

  • 24. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC, St Clair W, Owen AJ, Kennedy AR.
    Cancer Res; 1988 Apr 01; 48(7):1798-802. PubMed ID: 3280120
    [Abstract] [Full Text] [Related]

  • 25. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA, Paterson Y, Kennedy AR.
    Nutr Cancer; 1994 Apr 01; 22(2):185-93. PubMed ID: 14502847
    [Abstract] [Full Text] [Related]

  • 26. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
    Yavelow J, Caggana M, Beck KA.
    Cancer Res; 1987 Mar 15; 47(6):1598-601. PubMed ID: 3545448
    [Abstract] [Full Text] [Related]

  • 27. Bowman-Birk proteinase inhibitor (BBI) modulates radiosensitivity and radiation-induced differentiation of human fibroblasts in culture.
    Dittmann K, Löffler H, Bamberg M, Rodemann HP.
    Radiother Oncol; 1995 Feb 15; 34(2):137-43. PubMed ID: 7597212
    [Abstract] [Full Text] [Related]

  • 28. Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice.
    Wan XS, Ware JH, Zhang L, Newberne PM, Evans SM, Clark LC, Kennedy AR.
    Prostate; 1999 Dec 01; 41(4):243-52. PubMed ID: 10544297
    [Abstract] [Full Text] [Related]

  • 29. The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.
    Gran B, Tabibzadeh N, Martin A, Ventura ES, Ware JH, Zhang GX, Parr JL, Kennedy AR, Rostami AM.
    Mult Scler; 2006 Dec 01; 12(6):688-97. PubMed ID: 17262995
    [Abstract] [Full Text] [Related]

  • 30. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A.
    J Neurol Sci; 2008 Aug 15; 271(1-2):191-202. PubMed ID: 18544456
    [Abstract] [Full Text] [Related]

  • 31. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.
    Dittmann K, Mayer C, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2008 Mar 15; 86(3):375-82. PubMed ID: 18237807
    [Abstract] [Full Text] [Related]

  • 32. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia.
    Malkowicz SB, McKenna WG, Vaughn DJ, Wan XS, Propert KJ, Rockwell K, Marks SH, Wein AJ, Kennedy AR.
    Prostate; 2001 Jun 15; 48(1):16-28. PubMed ID: 11391683
    [Abstract] [Full Text] [Related]

  • 33. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.
    McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE.
    Nutr Cancer; 2007 Jun 15; 57(2):184-93. PubMed ID: 17571952
    [Abstract] [Full Text] [Related]

  • 34. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids.
    Foehr MW, Tomei LD, Goddard JG, Pemberton PA, Bathurst IC.
    Nutr Cancer; 1999 Jun 15; 34(2):199-205. PubMed ID: 10578488
    [Abstract] [Full Text] [Related]

  • 35. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 36. Imbibition of soybean seeds in warm water results in the release of copious amounts of Bowman-Birk protease inhibitor, a putative anticarcinogenic agent.
    Palavalli MH, Natarajan SS, Wang TT, Krishnan HB.
    J Agric Food Chem; 2012 Mar 28; 60(12):3135-43. PubMed ID: 22372424
    [Abstract] [Full Text] [Related]

  • 37. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
    Armstrong WB, Kennedy AR, Wan XS, Taylor TH, Nguyen QA, Jensen J, Thompson W, Lagerberg W, Meyskens FL.
    Clin Cancer Res; 2000 Dec 28; 6(12):4684-91. PubMed ID: 11156220
    [Abstract] [Full Text] [Related]

  • 38. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH, Billings PC, Carew JA, Keller-McGandy C, Newberne P, Kennedy AR.
    Cancer Res; 1990 Feb 01; 50(3):580-6. PubMed ID: 2297699
    [Abstract] [Full Text] [Related]

  • 39. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
    Kennedy AR, Kritchevsky D, Shen WC.
    Pharm Res; 2003 Dec 01; 20(12):1908-10. PubMed ID: 14725352
    [Abstract] [Full Text] [Related]

  • 40. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anti-carcinogenic agents.
    Persiani S, Yeung A, Shen WC, Kennedy AR.
    Carcinogenesis; 1991 Jun 01; 12(6):1149-52. PubMed ID: 2044199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.